ENXTPA:AKEChemicals
Assessing Arkema (ENXTPA:AKE)’s Valuation After a Prolonged Share Price Slide Despite Rising Profits
Arkema (ENXTPA:AKE) has drifted lower this year, leaving the shares down roughly 28% year to date and about 31% over the past year, even as earnings and revenue continue to grow.
See our latest analysis for Arkema.
That slide reflects a steady loss of confidence rather than a single shock, with the 90 day share price return of minus 12.53 percent and five year total shareholder return of minus 35.15 percent underscoring that momentum is still fading despite improving profits.
If Arkema’s...